XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)    
Revenues $ 4,057,069 $ 3,841,978
Cost of sales 2,078,437 2,477,086
Gross Profit 1,978,632 1,364,892
Operating Expenses:    
General and administrative 3,579,522 5,481,380
Research and development 1,582,343 2,184,924
Sales and marketing 977,875 1,180,529
Total Operating Expenses 6,139,740 8,846,833
Loss from Operations (4,161,108) (7,481,941)
Other Income (Expense):    
Interest expense, net (305,497) (16,332)
Other expense, net (132,894) (98,299)
Total Other Expense, net (438,391) (114,631)
Loss Before Income Taxes (4,599,499) (7,596,572)
Provision for income taxes 0 0
Net Loss attributable to common stockholders $ (4,599,499) $ (7,596,572)
Net Loss Per Common Share - Basic and Diluted $ (0.05) $ (0.10)
Weighted Average Number of Shares Outstanding During the Period - Basic and Diluted 89,649,999 77,923,660
Comprehensive Loss:    
Net Loss attributable to common stockholders $ (4,599,499) $ (7,596,572)
Amortization of unrecognized periodic pension costs 43,345 0
Foreign currency cumulative translation adjustment 51,259 20,172
Total comprehensive loss, net of tax (4,504,895) (7,576,400)
Accrued dividends on Series F Preferred Stock (66,921) 0
Deemed dividend on Series F Preferred Stock and warrant (255,976) 0
Total comprehensive loss available to common stockholder $ (4,827,792) $ (7,576,400)